InvivoGen's product citations
InvivoGen’s products are frequently cited in peer-reviewed publications for a wide variety of applications and uses. Browse our product citations below.
Please note: By clicking on the product name, you can access via the ‘Citations’ tab all references of the product (click ‘load more’).
Citations search
You can search by ‘Product Name’ or ‘Year’.
Product | Citation | Year | Journal | Authors | Page |
---|---|---|---|---|---|
R848 (Resiquimod) | Honeysuckle ( Lonicera japonica) and Huangqi ( Astragalus membranaceus) Suppr... | 2022 | Front Pharmacol. | Yeh Y.C. et al. | DOI: 10.3389/fphar.2021.765553 |
QUANTI-Blue™ | Dectin-1b activation by arabinoxylans induces trained immunity in human monoc... | 2022 | Int J Biol Macromol. | Moerings B.G.J. et al. | DOI: 10.1016/j.ijbiomac.2022.04.071 |
HEK-Blue™ Null1-v Cells | Dectin-1b activation by arabinoxylans induces trained immunity in human monoc... | 2022 | Int J Biol Macromol. | Moerings B.G.J. et al. | DOI: 10.1016/j.ijbiomac.2022.04.071 |
HEK-Blue™ hDectin-1b Cells | Dectin-1b activation by arabinoxylans induces trained immunity in human monoc... | 2022 | Int J Biol Macromol. | Moerings B.G.J. et al. | DOI: 10.1016/j.ijbiomac.2022.04.071 |
HEK-Blue™ hDectin-1a Cells | Dectin-1b activation by arabinoxylans induces trained immunity in human monoc... | 2022 | Int J Biol Macromol. | Moerings B.G.J. et al. | DOI: 10.1016/j.ijbiomac.2022.04.071 |
QUANTI-Blue™ | The efficacy of a 2,4-diaminoquinazoline compound as an intranasal vaccine ad... | 2022 | J Microbiol. | Noh K. et al. | DOI: 10.1007/s12275-022-1661-7 |
Mouse TLR8 Reporter HEK293 Cells (NF-κB) | The efficacy of a 2,4-diaminoquinazoline compound as an intranasal vaccine ad... | 2022 | J Microbiol. | Noh K. et al. | DOI: 10.1007/s12275-022-1661-7 |
Human TLR7 Reporter HEK293 Cells (NF-κB) | The efficacy of a 2,4-diaminoquinazoline compound as an intranasal vaccine ad... | 2022 | J Microbiol. | Noh K. et al. | DOI: 10.1007/s12275-022-1661-7 |
Mouse TLR7 Reporter HEK293 Cells (NF-κB) | The efficacy of a 2,4-diaminoquinazoline compound as an intranasal vaccine ad... | 2022 | J Microbiol. | Noh K. et al. | DOI: 10.1007/s12275-022-1661-7 |
HEK-Blue™ Null1 Cells | The efficacy of a 2,4-diaminoquinazoline compound as an intranasal vaccine ad... | 2022 | J Microbiol. | Noh K. et al. | DOI: 10.1007/s12275-022-1661-7 |
Human TLR8 Reporter HEK293 Cells (NF-κB) | The efficacy of a 2,4-diaminoquinazoline compound as an intranasal vaccine ad... | 2022 | J Microbiol. | Noh K. et al. | DOI: 10.1007/s12275-022-1661-7 |
Zeocin® | CatSper and its CaM-like Ca 2+ sensor EFCAB9 are necessary for the path chira... | 2022 | FASEB J. | Wiesehöfer C. et al. | DOI: 10.1096/fj.202101656RR |
Alhydrogel® adjuvant 2% | Lipidation of Haemophilus influenzae Antigens P6 and OMP26 Improves Immunogen... | 2022 | Infect Immun. | Kaur R. & Pichichero M. | DOI: 10.1128/iai.00678-21 |
Curdlan | Lipidation of Haemophilus influenzae Antigens P6 and OMP26 Improves Immunogen... | 2022 | Infect Immun. | Kaur R. & Pichichero M. | DOI: 10.1128/iai.00678-21 |
Puromycin | Effects of GSK-J4 on JMJD3 Histone Demethylase in Mouse Prostate Cancer Xenog... | 2022 | Cancer Genomics Proteomics | Sanchez A. et al. | DOI: 10.21873/cgp.20324 |
Plasmocin® - Mycoplasma Elimination Reagent | Robust delivery of RIG-I agonists using extracellular vesicles for anti-cance... | 2022 | J Extracell Vesicles | Peng B. et al. | DOI: 10.1002/jev2.12187 |
QUANTI-Luc™: Luciferase Detection Reagent | Robust delivery of RIG-I agonists using extracellular vesicles for anti-cance... | 2022 | J Extracell Vesicles | Peng B. et al. | DOI: 10.1002/jev2.12187 |
A549-Dual™ KO-RIG-I Cells | Robust delivery of RIG-I agonists using extracellular vesicles for anti-cance... | 2022 | J Extracell Vesicles | Peng B. et al. | DOI: 10.1002/jev2.12187 |
A549-Dual™ Cells | Robust delivery of RIG-I agonists using extracellular vesicles for anti-cance... | 2022 | J Extracell Vesicles | Peng B. et al. | DOI: 10.1002/jev2.12187 |
Anti-mouse Mincle (CLEC4E) antibody | Recognition of Tumor Nidogen-1 by Neutrophil C-Type Lectin Receptors. | 2022 | Biomedicines | Sionov R.V. et al. | DOI: 10.3390/biomedicines10040908 |